NCT00756847View on ClinicalTrials.gov

Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

May 31, 2012

Study Completion Date

October 31, 2012

Conditions
CancerNon-Small Cell Lung CancerEndometrial CarcinomaOvarian Carcinoma
Interventions
DRUG

XL147 (SAR245408),

Gelatin capsules supplied in 25- and 100-mg strengths; daily dosing

DRUG

paclitaxel

Intravenous injection dosed once every three weeks

DRUG

carboplatin

Intravenous injection dosed once every three weeks

Trial Locations (4)

63110

Investigational Site Number, St Louis

73104

Investigational Site Number, Oklahoma City

77030-4009

Investigational Site Number, Houston

53792-6164

Investigational Site Number, Madison

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY